JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - CHF (hedged)/  LU2053353749  /

Fonds
NAV2024-06-05 Chg.+0.0900 Type of yield Investment Focus Investment company
90.8200CHF +0.10% paying dividend Equity Worldwide JPMorgan AM (EU)